Early antiretroviral therapy favours post-treatment SIV control, which is associated with enhanced CD8+ T-cell antiviral activity against rebounding virus - the pVISCONTI study

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Journal of the International AIDS Society 2021-07, Vol.24 (S4), p.11
Hauptverfasser:	Passaes, C, Desjardins, D, Avettand-Fenoel, V, Chapel, A, Monceaux, V, Melard, A, Dimant, N, Perdomo-Celis, F, David, A, Barrail-Tran, A, Lambotte, O, Guedj, J, Dereuddre-Bosquet, N, Muller-Trutwin, M, Rouzioux, C, Grand, R Le, Saez-Cirion, A
Format:	Artikel
Sprache:	eng
Schlagworte:	Antiviral agents CD8 lymphocytes Development and progression Drug therapy Health aspects HIV infection Immune response Observations Patient outcomes
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!